Apellis Announces 5-Year GALE Data Showing SYFOVRE® (pegcetacoplan injection) Delayed Progression of Geographic Atrophy by ~1.5 Years

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...
BMJ Case Reports

Acute necrotising pancreatitis in a patient with Behçet’s disease

A man in his 40s of Middle Eastern descent, with no prior medical history, presented with severe abdominal pain that had ...